These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 30132692)

  • 1. From Wary Wearers to d-Embracers: Personas of Readiness to Use Diabetes Devices.
    Tanenbaum ML; Adams RN; Iturralde E; Hanes SJ; Barley RC; Naranjo D; Hood KK
    J Diabetes Sci Technol; 2018 Nov; 12(6):1101-1107. PubMed ID: 30132692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using Cluster Analysis to Understand Clinician Readiness to Promote Continuous Glucose Monitoring Adoption.
    Tanenbaum ML; Adams RN; Lanning MS; Hanes SJ; Agustin BI; Naranjo D; Hood KK
    J Diabetes Sci Technol; 2018 Nov; 12(6):1108-1115. PubMed ID: 29991281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parental Perspectives: Identifying Profiles of Parental Attitudes and Barriers Related to Diabetes Device Use.
    Wong JJ; Barley RC; Hanes S; Tanenbaum ML; Lanning M; Naranjo D; Hood KK
    Diabetes Technol Ther; 2020 Sep; 22(9):674-680. PubMed ID: 31971451
    [No Abstract]   [Full Text] [Related]  

  • 4. Diabetes Device Use in Adults With Type 1 Diabetes: Barriers to Uptake and Potential Intervention Targets.
    Tanenbaum ML; Hanes SJ; Miller KM; Naranjo D; Bensen R; Hood KK
    Diabetes Care; 2017 Feb; 40(2):181-187. PubMed ID: 27899489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychosocial Aspects of Diabetes Technology: Adult Perspective.
    Polonsky WH
    Endocrinol Metab Clin North Am; 2020 Mar; 49(1):143-155. PubMed ID: 31980114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost, Hassle, and On-Body Experience: Barriers to Diabetes Device Use in Adolescents and Potential Intervention Targets.
    Messer LH; Tanenbaum ML; Cook PF; Wong JJ; Hanes SJ; Driscoll KA; Hood KK
    Diabetes Technol Ther; 2020 Oct; 22(10):760-767. PubMed ID: 32163719
    [No Abstract]   [Full Text] [Related]  

  • 7. CGM Benefits and Burdens: Two Brief Measures of Continuous Glucose Monitoring.
    Messer LH; Cook PF; Tanenbaum ML; Hanes S; Driscoll KA; Hood KK
    J Diabetes Sci Technol; 2019 Nov; 13(6):1135-1141. PubMed ID: 30854886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimal Use of Diabetes Devices: Clinician Perspectives on Barriers and Adherence to Device Use.
    Tanenbaum ML; Adams RN; Hanes SJ; Barley RC; Miller KM; Mulvaney SA; Hood KK
    J Diabetes Sci Technol; 2017 May; 11(3):484-492. PubMed ID: 28745093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a New Measure for Assessing Glucose Monitoring Device-Related Treatment Satisfaction and Quality of Life.
    Polonsky WH; Fisher L; Hessler D; Edelman SV
    Diabetes Technol Ther; 2015 Sep; 17(9):657-63. PubMed ID: 25923812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetes technology and treatments in the paediatric age group.
    Shalitin S; Peter Chase H
    Int J Clin Pract Suppl; 2011 Feb; (170):76-82. PubMed ID: 21323816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adapting and validating a measure of diabetes-specific self-compassion.
    Tanenbaum ML; Adams RN; Gonzalez JS; Hanes SJ; Hood KK
    J Diabetes Complications; 2018 Feb; 32(2):196-202. PubMed ID: 29157869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acceptability of Implantable Continuous Glucose Monitoring Sensor.
    Barnard KD; Kropff J; Choudhary P; Neupane S; Bain SC; Kapitza C; Forst T; Link M; Mdingi C; DeVries JH
    J Diabetes Sci Technol; 2018 May; 12(3):634-638. PubMed ID: 28990436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistent heterogeneity in diabetes technology reimbursement for children with type 1 diabetes: The SWEET perspective.
    Sumnik Z; Szypowska A; Iotova V; Bratina N; Cherubini V; Forsander G; Jali S; Raposo JF; Stipančic G; Vazeou A; Veeze H; Lange K;
    Pediatr Diabetes; 2019 Jun; 20(4):434-443. PubMed ID: 30773756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Real-time continuous glucose monitoring in type 1 diabetes: a qualitative framework analysis of patient narratives.
    Pickup JC; Ford Holloway M; Samsi K
    Diabetes Care; 2015 Apr; 38(4):544-50. PubMed ID: 25552422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychosocial aspects of diabetes technology.
    Kubiak T; Priesterroth L; Barnard-Kelly KD
    Diabet Med; 2020 Mar; 37(3):448-454. PubMed ID: 31943354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolonged use of continuous glucose monitors in children with type 1 diabetes on continuous subcutaneous insulin infusion or intensive multiple-daily injection therapy.
    ; Weinzimer S; Xing D; Tansey M; Fiallo-Scharer R; Mauras N; Wysocki T; Beck R; Tamborlane W; Ruedy K
    Pediatr Diabetes; 2009 Apr; 10(2):91-6. PubMed ID: 19175899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diabetes Technology and the Human Factor.
    Liberman A; Barnard K
    Diabetes Technol Ther; 2019 Feb; 21(S1):S138-S147. PubMed ID: 30785329
    [No Abstract]   [Full Text] [Related]  

  • 18. Psychological Reactions Associated With Continuous Glucose Monitoring in Youth.
    Patton SR; Clements MA
    J Diabetes Sci Technol; 2016 May; 10(3):656-61. PubMed ID: 26969141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Barriers to Glucose Testing and Attitudes Toward Mobile App and Device Use in a Large Cohort of T1D Pediatric Patients: Implications for Diabetes Management.
    Barnes TL; Lee S; Thompson N; Mullen K; Chatterton P; Gandrud L
    J Diabetes Sci Technol; 2018 Nov; 12(6):1246-1247. PubMed ID: 30136595
    [No Abstract]   [Full Text] [Related]  

  • 20. Psychosocial Aspects of Continuous Glucose Monitoring: Connecting to the Patients' Experience.
    Kubiak T; Mann CG; Barnard KC; Heinemann L
    J Diabetes Sci Technol; 2016 Jul; 10(4):859-63. PubMed ID: 27234808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.